The Food and Drug Administration (FDA) is an HHS agency that regulates clinical investigations of products under its jurisdiction, such as drugs, biological products, and medical devices.
The FDA (R13) Scientific Conference Grant Program aims to support high-quality conferences and scientific meetings that are aligned with the FDA's mission. These events are intended to facilitate discussion and exchange of information on topics that impact public health within the FDA's purview. The program supports symposiums, seminars, workshops, or any formal meeting that can be conducted face-to-face or virtually. Although submitting an application does not guarantee funding, this initiative underscores the FDA's commitment to fostering environments where scientific inquiry and public health concerns can be explored in depth.